Related Experiment Video
Updated: Jul 19, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Insights
Bronchiolitis, a common infant respiratory infection, involves airway inflammation and mucus. This guideline offers evidence-based recommendations for its diagnosis, management, and prevention, including specific treatments and infection control strategies.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Bronchiolitis is the most frequent lower respiratory infection in infants, typically caused by viruses.
- It presents with acute inflammation, edema, epithelial necrosis, increased mucus, and bronchospasm in small airways.
Purpose of the Study:
- To develop evidence-based clinical practice guideline recommendations for the diagnosis, management, and prevention of bronchiolitis in infants.
- To synthesize current evidence on therapeutic interventions and infection control.
Main Methods:
- A comprehensive review of the evidence-based literature was conducted by a multidisciplinary committee.
- Recommendations were formulated based on systematic grading of evidence quality and strength of recommendation.
Main Results:
- The guideline addresses diagnosis, therapeutic interventions (bronchodilators, corticosteroids, antivirals, hydration, chest physiotherapy, oxygen), and prevention (palivizumab for RSV).
- Recommendations cover the control of nosocomial spread of infection.
Conclusions:
- This clinical practice guideline aims to assist clinicians in decision-making for managing bronchiolitis in children.
- It emphasizes that the guideline is a resource and not a substitute for clinical judgment or a universal protocol.
Abstract:
Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm. The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations. This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics. This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
COPD: Management Using Bronchodilators and Corticosteroids
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Nursing Management
First, in...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
